Promising news on the possibilities of using anti-retroviral meds as a method of HIV prevention ...
In its June issue, POZ examines the possibilities around HIV negative persons using tenofovir—the potent anti-retroviral drug marketed by Gilead Sciences under the trade name Viread—before potential exposure to the virus. The article suggests "pre-exposure prophylaxis", or PrEP, "seems to present one of the most promising fronts in prevention research." But can this be effective in preventing HIV among high-risk groups, such as the many black men who have sex with other men and do not identify as gay?
POZ reports the Centers for Disease Controls is planning to conduct a trial among 400 MSM in Atlanta, Boston and San Francisco to determine whether ARVs are safe for daily use among HIV-negative persons and whether taking the meds brings a "false sense of security" that leads to high-risk behavior.
Jagged Little Pills [POZ]
Some Background ...
FDA Recommends Marviroc [R20]
News: HIV Party Drug [R20]
"Urban Rally Against AIDS" [R20]
The HIV Morning After Pill? [R20]
Black Gay Men and "The Pill" [R20]
Jonathan Perry in "The Advocate" [R20]
Primetime Reports Black HIV Epidemic [After Elton]
"Out of Control: AIDS in Black America" [R20]